315.677.84002521 US Rt 11 LaFayette NY 13084
Ichor Therapeutics, Inc.

Leadership Team

CEO and Founder

Dr. Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, he has built Ichor from a living room start-up into a premier, vertically integrated research organization. Dr. Moody received a PhD in biochemistry and molecular biology from Miami’s Miller School of Medicine and an MBA from Concordia University Wisconsin.

Dr. Kelsey Moody, CEO at Ichor in LaFayette, NY
Aaron Wolfe, Ph.D., CSO and Partner at Ichor in LaFayette, NY

CSO and Partner

Dr. Wolfe is an entrepreneur and biophysicist. Prior to joining Ichor, he co-founded Finger Lakes Bio, a boutique protein engineering company. He previously served as biotechnology consultant to RLH, a private investment company. Dr. Wolfe holds a PhD in structural biology, biochemistry, and biophysics from Syracuse University and a certificate in entrepreneurship from the Warton School.

CMO

Dr. Cornelis (Cees) Wortel is a (bio) pharmaceutical Chief Medical Officer with 25+ years of experience in and with large and small companies, US and international. He has a successful track record designing and implementing R&D and clinical development plans, regulatory strategy and agency interactions, pharmacovigilance, corporate strategy, managing businesses and leading teams.

After serving in increasing clinical development positions at Centocor, Repligen, Procept, and Alkermes, Dr. Wortel founded an international CRO (Clinquest) which was acquired in 2015. He was involved in multiple successful drug development projects in a wide variety of disease indications and NCE / medical devices (including the Remicade while at Centocor). He is a Venture Partner at Vesalius Biocapital III.

Cornelis Wortel, MD, PhD, Chief Medical Officer at Ichor in LaFayette, NY